Announcement of Requirements and Registration for the 2014 Food and Drug Administration Food Safety Challenge, 57110-57112 [2014-22682]
Download as PDF
57110
Federal Register / Vol. 79, No. 185 / Wednesday, September 24, 2014 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hrs.)
Type of respondents
Form name
Residents, first responders, business owners,
employees, customers.
General Survey ..............................................
800
1
30/60
Rapid Response Registry Form .....................
Household Survey ..........................................
Hospital Survey ..............................................
Medical Chart Abstraction Form ....................
50
110
40
250
1
1
1
1
7/60
15/60
30/60
30/60
Veterinary Chart Abstraction Form ................
30
1
20/60
Residents ........................................................
Hospital staff ...................................................
Staff from state, local, or tribal health agencies.
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–22691 Filed 9–23–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Barbara Bowman
Janet Collins
Hazel Dean
Jane Gentleman
Joseph Henderson
Jeffrey Napier
Jennifer Parker
Tom Sinks
Kalwant Smagh
James Stephens
Dated: September 19, 2014.
Ron A. Otten,
Acting Deputy Associate Director for Science,
Centers for Disease Control and Prevention.
Centers for Disease Control and
Prevention
[FR Doc. 2014–22714 Filed 9–23–14; 8:45 am]
Performance Review Board Members
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
AGENCY:
The Centers for Disease
Control and Prevention (CDC) located
within the Department of Health and
Human Services (HHS) is publishing the
names of the Performance Review Board
Members who are reviewing
performance for Fiscal Year 2014.
FOR FURTHER INFORMATION CONTACT:
Sharon O’Brien, Deputy Director,
Executive and Scientific Resources
Office, Human Capital and Resources
Management Office, Centers for Disease
Control and Prevention, 4770 Buford
Highway, NE., Mailstop K–15, Atlanta,
Georgia 30341, Telephone (770) 488–
1781.
SUMMARY:
Title 5,
U.S.C. 4314(c)(4) of the Civil Service
Reform Act of 1978, Public Law 95–454,
requires that the appointment of
Performance Review Board Members be
published in the Federal Register. The
following persons will serve on the CDC
Performance Review Boards or Panels,
which will oversee the evaluation of
performance appraisals of Senior
Executive Service members for the
Fiscal Year 2014 review period:
Christine Branche, Co-Chair
James Seligman, Co-Chair
asabaliauskas on DSK5VPTVN1PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
18:41 Sep 23, 2014
Jkt 232001
Food and Drug Administration
[Docket No. FDA–2014–N–1287]
Announcement of Requirements and
Registration for the 2014 Food and
Drug Administration Food Safety
Challenge
Authority: 15 U.S.C. 3719.
Food and Drug Administration,
HHS.
Award Approving Official: Erik
Mettler, Deputy Associate
Commissioner, Food and Drug
Administration/Office of Foods and
Veterinary Medicine.
ACTION: Notice.
AGENCY:
The Food and Drug
Administration (FDA) is announcing the
2014 FDA Food Safety Challenge, a
prize competition under the America
COMPETES Reauthorization Act of
2010. The 2014 FDA Food Safety
Challenge is an effort to advance
breakthroughs in foodborne pathogen
detection, specifically with the goal of
accelerating the detection of Salmonella
in fresh produce. As FDA’s food safety
program incorporates preventive control
measures through the implementation of
SUMMARY:
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
the FDA Food Safety Modernization
Act, quicker detection of these harmful
bacteria will help to prevent foodborne
illnesses.
DATES:
1. Phase I submission period:
September 23 to November 9, 2014.
2. Phase II judging of submissions and
selection of finalists: November 10,
2014, to January 6, 2015.
3. Phase III field accelerator, inclusive
of finalist mentorship, boot camp, and
demo day: January 8 to March 5, 2015.
4. Phase IV final judging: March 5 to
March 11, 2015.
5. Winner(s) announced: March 12,
2015.
FOR FURTHER INFORMATION CONTACT:
Chad P. Nelson, Office of Foods and
Veterinary Medicine, Food and Drug
Administration, 10903 New Hampshire
Ave., Silver Spring, MD 20993, 301–
796–4643.
SUPPLEMENTARY INFORMATION:
I. Background
While the American food supply is
among the safest in the world, the
Centers for Disease Control and
Prevention (CDC) estimates that 1 in 6
Americans is sickened by foodborne
illness annually, resulting in about
3,000 deaths each year. It is estimated
that the overall negative economic
impact of foodborne illness in the
United States, including medical costs,
quality-of-life losses, lost productivity,
and lost-life expectancy, may be as high
as $77 billion per year. Salmonella
represents the leading cause of deaths
and of hospitalizations related to
foodborne illness. Contaminated
produce is responsible for nearly half of
foodborne illnesses and almost a quarter
of foodborne-related deaths.
The 2014 FDA Food Safety Challenge
is a call to scientists, academics,
entrepreneurs, and innovators from all
disciplines to submit concepts applying
novel and/or advanced methodologies
to foster revolutionary improvements in
foodborne pathogen detection.
E:\FR\FM\24SEN1.SGM
24SEN1
Federal Register / Vol. 79, No. 185 / Wednesday, September 24, 2014 / Notices
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Specifically, concepts should apply
cutting-edge techniques to achieve
significant improvements in the speed
of the FDA’s detection methods for
Salmonella with identification to the
subtype/serovar level in minimally
processed fresh produce. FDA is most
interested in concepts that explore the
acceleration or elimination of sample
preparation and/or enrichment in the
testing process, and/or those that
employ novel or revolutionary
techniques to achieve pathogen
detection. Concepts may combine new
techniques with existing methodologies,
such as polymerase chain reaction, and
must describe where time savings are
achieved in the testing process as well
as the expected time from unprepared
food sample to verifiable result.
The statutory authority for this
challenge competition is section 105 of
the America COMPETES
Reauthorization Act of 2010 (Pub. L.
111–358).
II. Subject of the Challenge Competition
The primary goal of the challenge is
to advance breakthroughs in foodborne
pathogen detection, specifically to
significantly accelerate detection of
Salmonella in produce, in order to
support FDA’s effort to ensure the safety
of America’s food supply.
The secondary goals of the challenge
are:
• To bring new innovators to FDA’s
foodborne pathogen testing processes;
• To increase public awareness about
food safety, foodborne pathogen testing,
and FDA’s role in those areas; and
• To promote open government and
citizen participation to improve
innovation in the Federal Government.
This challenge is designed to solicit
breakthrough solutions from advanced
scientific and research areas, such as,
but not limited to metagenomics (or
other next-generation sequencing
methods), spectroscopy, application of
nanotubes/nanotechnology, quantum
detection methods, and electrical
detection methods. Although concepts
must specifically be able to address the
detection of Salmonella, with
identification to the subtype/serovar
level, in minimally processed fresh
produce, the ability of the solution to
address testing for other microbial
pathogens and in other foods or
complex matrices is encouraged.
Submissions must describe how the
technique would increase speed of
pathogen detection efforts (starting from
an unprepared food sample, through
verification of pathogen(s)) without
sacrificing specificity and sensitivity or
comparability reference methods. FDA
is most interested in methods that
VerDate Sep<11>2014
18:41 Sep 23, 2014
Jkt 232001
would accelerate or eliminate sample
preparation and/or enrichment in the
testing process. Submitted concepts can
be targeted at any point in the food
system (i.e. harvest, packaging,
distribution, point of sale, etc.), however
concepts should specify which point(s)
they are targeting and how the
technique would be implemented.
Though submissions may be theoretical
in terms of application to food safety, all
entries must be able to demonstrate a
path to practical development of their
concept and a plan to move to proof of
concept over the course of the
challenge. Submissions should include
relevant data with reference to use of
the concept/technique, such as any
initial verification results, any available
proof of concept, or relevant data from
the technique’s use in adjacent
industries. During the field accelerator
phase, which will include a live boot
camp, finalists will refine their
submissions with the assistance of FDA
food safety and pathogen testing
experts. Feedback will focus on helping
finalists to clarify their concepts and
ensure they are in line with FDA’s
needs and capabilities, maximize
impact on food safety, and can be
reasonably executed. At the end of the
field accelerator phase, finalists will
present their refined concepts to the
judges at a demo day and provide a final
report describing how their submission
was modified based on the feedback
from FDA subject matter experts.
III. Eligibility Rules for Participating in
the Competition
To be eligible to win a prize under
this challenge, an individual or entity:
• Must have entered a submission on
www.foodsafetychallenge.com under the
rules promulgated by FDA.
• Must have complied with all the
requirements under this section.
• Must be (1) an individual or team
of U.S. citizens or permanent residents
of the United States each of whom are
18 years of age and over or (2) an entity
incorporated in and maintaining a
primary place of business in the United
States. Foreign citizens can participate
as employees of an entity that is
properly incorporated in the United
States and maintains a primary place of
business in the United States.
• May not be a Federal entity or
Federal employee acting within the
scope of their employment. An
individual or entity shall not be deemed
ineligible because the individual or
entity used Federal facilities or
consulted with Federal employees
during a competition if the facilities and
employees are made available to all
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
57111
individuals and entities participating in
the competition on an equitable basis.
Federal grantees may not use Federal
funds to develop COMPETES Act
challenge applications unless consistent
with the purpose of their grant award.
Federal contractors may not use Federal
funds from a contract to develop
COMPETES Act challenge applications
or to fund efforts in support of a
COMPETES Act challenge submission.
Employees of FDA, the U.S.
Department of Agriculture’s Food Safety
and Inspection Service, the CDC,
Luminary Labs, LLC, each of their
affiliates, and/or any other individual or
entity associated with the development,
evaluation, or administration of the
challenge as well as members of such
persons’ immediate families (spouses,
children, siblings, parents), and persons
living in the same household as such
persons, whether or not related, are not
eligible to participate in the challenge.
Entrants must agree to assume any
and all risks and waive claims against
the Federal Government and its related
entities, except in the case of willful
misconduct, for any injury, death,
damage, or loss of property, revenue, or
profits, whether direct, indirect, or
consequential, arising from their
participation in a competition, whether
the injury, death, damage, or loss arises
through negligence or otherwise.
Entrants must also agree to indemnify
the Federal Government against thirdparty claims for damages arising from or
related to competition activities.
Entrants are not required to obtain
liability insurance or demonstrate
financial responsibility in order to
participate in the challenge.
By participating in the challenge, each
entrant who works with pathogenic
organisms such as Salmonella in
support of its submission agrees to
follow the requirements for Biosafety
Level II laboratory operations, as
outlined in the 5th edition of ‘‘Biosafety
in Microbiological and Biomedical
Laboratories,’’ available at https://
www.cdc.gov/biosafety/publications/
bmbl5/.
IV. Registration Process for Participants
To register for the 2014 FDA Food
Safety Challenge, participants can
access https://foodsafetychallenge.com/
and click on Submission Form.
V. Amount of the Prize
The total prize pool for the 2014 FDA
Food Safety Challenge is $500,000.
From the $500,000 prize pool, up to 5
finalists will be awarded $20,000 each
following the open submission phase
and judging of submissions. After the
field accelerator phase and final
E:\FR\FM\24SEN1.SGM
24SEN1
57112
Federal Register / Vol. 79, No. 185 / Wednesday, September 24, 2014 / Notices
judging, the winner(s) will receive the
remainder of the prize money.
VI. Payment of the Prize
Prizes awarded under this
competition will be paid by electronic
funds transfer and may be subject to
Federal income taxes. FDA will comply
with the Internal Revenue Service
withholding and reporting
requirements, where applicable.
VII. Basis Upon Which Winner(s) Will
Be Selected
A panel of expert judges will select up
to five finalist teams from the pool of
eligible entries. These finalists will then
refine their concepts during the field
accelerator phase and will present the
concept at demo day. The judging will
be based and scored upon the judges’
own discretion as to the quality of each
entry according to the following finalist
evaluation criteria, with equal weighting
(i.e., 20 percent for each).
asabaliauskas on DSK5VPTVN1PROD with NOTICES
A. Finalist Evaluation Criteria
• Speed: Proposed reduction in time
from unprepared food sample to verified
pathogen to subtype/serovar level for
Salmonella in fresh, minimally
processed produce. The ability of the
solution to also address testing in other
foods and other complex matrices is
encouraged. The ability of the technique
to also address additional pathogens
such as Shiga toxin-producing
Escherichia coli is encouraged.
• Improved detection and path to
impact: Strength of evidence, data, and/
or argumentation regarding the
application of submission’s technique to
create impactful acceleration and
improvement of foodborne pathogen
detection, inclusive of improvements in
specificity and sensitivity for
Salmonella and possibly other
pathogens.
• Applicability: Applicability of
solution to FDA testing processes.
• Revolutionary: Whether the concept
would be a revolutionary improvement
over the FDA’s current testing
procedures with potential to make a
major impact on food testing.
• Execution: Perceived ability of
submitting team or individual to
execute and develop their concept.
B. Winner Selection Criteria
Winner selection criteria will include
finalist evaluation criteria plus the
following criterion: Demonstration of
team’s/individual’s ability to effectively
iterate and improve their concept over
the course of the field accelerator phase.
VIII. Additional Information
FDA reserves the right to suspend,
postpone, terminate, or otherwise
VerDate Sep<11>2014
18:41 Sep 23, 2014
Jkt 232001
modify the challenge, or any entrant’s
participation in the challenge, at any
time at FDA’s discretion.
IX. Intellectual Property
Entrants retain ownership of their
concepts, including any software,
research, or other intellectual property
that they develop in connection
therewith, subject to the license granted
to FDA to use publicly posted materials
as set forth herein. By participating in
the challenge, each entrant hereby
irrevocably grants to FDA and Luminary
Labs, LLC, a limited, non-exclusive,
royalty free, worldwide license and
right to reproduce, publicly perform,
publicly display, and use the
submission to the extent necessary to
administer the challenge, and to
publicly perform and publicly display
the submission abstract, including,
without limitation, for advertising and
promotional purposes relating to the
challenge.
Entrants retain all rights in the
submission and any invention or work,
including any software, submitted as
part of the submission, subject to the
following:
• A nonexclusive, nontransferrable,
irrevocable, paid-up license to practice
or have practiced for or on behalf of the
United States any such invention or
work throughout the world, should the
submission win; and
• A license in the submission or work
submitted as part of the submission for
the United States to use, disclose,
reproduce, prepare derivative works,
distribute copies to the public, and
perform publicly and display publicly,
in any manner and for any purpose, and
to have or permit others to do so, should
the submission win.
Dated: September 18, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014–22682 Filed 9–23–14; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2013–D–1601]
Custom Device Exemption; Guidance
for Industry and Food and Drug
Administration Staff; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing the
availability of the guidance entitled
SUMMARY:
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
‘‘Custom Device Exemption.’’ FDA has
developed this document to provide
guidance to industry and FDA staff
about implementation of the custom
device exemption contained in the
Food, Drug, and Cosmetic Act (the
FD&C Act). The intent of this guidance
is to define terms used in the custom
device exemption, explain how to
interpret the ‘‘five units per year of a
particular device type’’ language
contained in the FD&C Act, describe
information that FDA proposes
manufacturers should submit in the
custom device annual report, and
provide recommendations on how to
submit an annual report for devices
distributed under the custom device
exemption.
DATES: Submit either electronic or
written comments on this guidance at
any time. General comments on Agency
guidance documents are welcome at any
time.
ADDRESSES: An electronic copy of the
guidance document is available for
download from the Internet. See the
SUPPLEMENTARY INFORMATION section for
information on electronic access to the
guidance. Submit written requests for a
single hard copy of the draft guidance
document entitled ‘‘Custom Device
Exemption’’ to the Office of the Center
Director, Guidance and Policy
Development, Center for Devices and
Radiological Health, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 66, rm. 4613, Silver Spring,
MD 20993–0002. Send one selfaddressed adhesive label to assist that
office in processing your request.
Submit electronic comments on the
guidance to https://www.regulations.gov.
Submit written comments to the
Division of Dockets Management (HFA–
305), Food and Drug Administration,
5630 Fishers Lane, rm. 1061, Rockville,
MD 20852. Identify comments with the
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT:
Division of Premarket and Labeling
Compliance, Center for Devices and
Radiological Health, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 66, Silver Spring, MD
20993–0002, 301–796–5770,
CustomDevices@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
The custom device exemption is set
forth at section 520(b) of the FD&C Act
(21 U.S.C. 360j(b)). A custom device is
in a narrow category of devices for
which, because of the rarity of a
patient’s medical condition or a
physician’s special need, compliance
E:\FR\FM\24SEN1.SGM
24SEN1
Agencies
[Federal Register Volume 79, Number 185 (Wednesday, September 24, 2014)]
[Notices]
[Pages 57110-57112]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-22682]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2014-N-1287]
Announcement of Requirements and Registration for the 2014 Food
and Drug Administration Food Safety Challenge
Authority: 15 U.S.C. 3719.
AGENCY: Food and Drug Administration, HHS.
Award Approving Official: Erik Mettler, Deputy Associate
Commissioner, Food and Drug Administration/Office of Foods and
Veterinary Medicine.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing the 2014
FDA Food Safety Challenge, a prize competition under the America
COMPETES Reauthorization Act of 2010. The 2014 FDA Food Safety
Challenge is an effort to advance breakthroughs in foodborne pathogen
detection, specifically with the goal of accelerating the detection of
Salmonella in fresh produce. As FDA's food safety program incorporates
preventive control measures through the implementation of the FDA Food
Safety Modernization Act, quicker detection of these harmful bacteria
will help to prevent foodborne illnesses.
DATES:
1. Phase I submission period: September 23 to November 9, 2014.
2. Phase II judging of submissions and selection of finalists:
November 10, 2014, to January 6, 2015.
3. Phase III field accelerator, inclusive of finalist mentorship,
boot camp, and demo day: January 8 to March 5, 2015.
4. Phase IV final judging: March 5 to March 11, 2015.
5. Winner(s) announced: March 12, 2015.
FOR FURTHER INFORMATION CONTACT: Chad P. Nelson, Office of Foods and
Veterinary Medicine, Food and Drug Administration, 10903 New Hampshire
Ave., Silver Spring, MD 20993, 301-796-4643.
SUPPLEMENTARY INFORMATION:
I. Background
While the American food supply is among the safest in the world,
the Centers for Disease Control and Prevention (CDC) estimates that 1
in 6 Americans is sickened by foodborne illness annually, resulting in
about 3,000 deaths each year. It is estimated that the overall negative
economic impact of foodborne illness in the United States, including
medical costs, quality-of-life losses, lost productivity, and lost-life
expectancy, may be as high as $77 billion per year. Salmonella
represents the leading cause of deaths and of hospitalizations related
to foodborne illness. Contaminated produce is responsible for nearly
half of foodborne illnesses and almost a quarter of foodborne-related
deaths.
The 2014 FDA Food Safety Challenge is a call to scientists,
academics, entrepreneurs, and innovators from all disciplines to submit
concepts applying novel and/or advanced methodologies to foster
revolutionary improvements in foodborne pathogen detection.
[[Page 57111]]
Specifically, concepts should apply cutting-edge techniques to achieve
significant improvements in the speed of the FDA's detection methods
for Salmonella with identification to the subtype/serovar level in
minimally processed fresh produce. FDA is most interested in concepts
that explore the acceleration or elimination of sample preparation and/
or enrichment in the testing process, and/or those that employ novel or
revolutionary techniques to achieve pathogen detection. Concepts may
combine new techniques with existing methodologies, such as polymerase
chain reaction, and must describe where time savings are achieved in
the testing process as well as the expected time from unprepared food
sample to verifiable result.
The statutory authority for this challenge competition is section
105 of the America COMPETES Reauthorization Act of 2010 (Pub. L. 111-
358).
II. Subject of the Challenge Competition
The primary goal of the challenge is to advance breakthroughs in
foodborne pathogen detection, specifically to significantly accelerate
detection of Salmonella in produce, in order to support FDA's effort to
ensure the safety of America's food supply.
The secondary goals of the challenge are:
To bring new innovators to FDA's foodborne pathogen
testing processes;
To increase public awareness about food safety, foodborne
pathogen testing, and FDA's role in those areas; and
To promote open government and citizen participation to
improve innovation in the Federal Government.
This challenge is designed to solicit breakthrough solutions from
advanced scientific and research areas, such as, but not limited to
metagenomics (or other next-generation sequencing methods),
spectroscopy, application of nanotubes/nanotechnology, quantum
detection methods, and electrical detection methods. Although concepts
must specifically be able to address the detection of Salmonella, with
identification to the subtype/serovar level, in minimally processed
fresh produce, the ability of the solution to address testing for other
microbial pathogens and in other foods or complex matrices is
encouraged. Submissions must describe how the technique would increase
speed of pathogen detection efforts (starting from an unprepared food
sample, through verification of pathogen(s)) without sacrificing
specificity and sensitivity or comparability reference methods. FDA is
most interested in methods that would accelerate or eliminate sample
preparation and/or enrichment in the testing process. Submitted
concepts can be targeted at any point in the food system (i.e. harvest,
packaging, distribution, point of sale, etc.), however concepts should
specify which point(s) they are targeting and how the technique would
be implemented. Though submissions may be theoretical in terms of
application to food safety, all entries must be able to demonstrate a
path to practical development of their concept and a plan to move to
proof of concept over the course of the challenge. Submissions should
include relevant data with reference to use of the concept/technique,
such as any initial verification results, any available proof of
concept, or relevant data from the technique's use in adjacent
industries. During the field accelerator phase, which will include a
live boot camp, finalists will refine their submissions with the
assistance of FDA food safety and pathogen testing experts. Feedback
will focus on helping finalists to clarify their concepts and ensure
they are in line with FDA's needs and capabilities, maximize impact on
food safety, and can be reasonably executed. At the end of the field
accelerator phase, finalists will present their refined concepts to the
judges at a demo day and provide a final report describing how their
submission was modified based on the feedback from FDA subject matter
experts.
III. Eligibility Rules for Participating in the Competition
To be eligible to win a prize under this challenge, an individual
or entity:
Must have entered a submission on
www.foodsafetychallenge.com under the rules promulgated by FDA.
Must have complied with all the requirements under this
section.
Must be (1) an individual or team of U.S. citizens or
permanent residents of the United States each of whom are 18 years of
age and over or (2) an entity incorporated in and maintaining a primary
place of business in the United States. Foreign citizens can
participate as employees of an entity that is properly incorporated in
the United States and maintains a primary place of business in the
United States.
May not be a Federal entity or Federal employee acting
within the scope of their employment. An individual or entity shall not
be deemed ineligible because the individual or entity used Federal
facilities or consulted with Federal employees during a competition if
the facilities and employees are made available to all individuals and
entities participating in the competition on an equitable basis.
Federal grantees may not use Federal funds to develop COMPETES Act
challenge applications unless consistent with the purpose of their
grant award. Federal contractors may not use Federal funds from a
contract to develop COMPETES Act challenge applications or to fund
efforts in support of a COMPETES Act challenge submission.
Employees of FDA, the U.S. Department of Agriculture's Food Safety
and Inspection Service, the CDC, Luminary Labs, LLC, each of their
affiliates, and/or any other individual or entity associated with the
development, evaluation, or administration of the challenge as well as
members of such persons' immediate families (spouses, children,
siblings, parents), and persons living in the same household as such
persons, whether or not related, are not eligible to participate in the
challenge.
Entrants must agree to assume any and all risks and waive claims
against the Federal Government and its related entities, except in the
case of willful misconduct, for any injury, death, damage, or loss of
property, revenue, or profits, whether direct, indirect, or
consequential, arising from their participation in a competition,
whether the injury, death, damage, or loss arises through negligence or
otherwise.
Entrants must also agree to indemnify the Federal Government
against third-party claims for damages arising from or related to
competition activities.
Entrants are not required to obtain liability insurance or
demonstrate financial responsibility in order to participate in the
challenge.
By participating in the challenge, each entrant who works with
pathogenic organisms such as Salmonella in support of its submission
agrees to follow the requirements for Biosafety Level II laboratory
operations, as outlined in the 5th edition of ``Biosafety in
Microbiological and Biomedical Laboratories,'' available at https://www.cdc.gov/biosafety/publications/bmbl5/.
IV. Registration Process for Participants
To register for the 2014 FDA Food Safety Challenge, participants
can access https://foodsafetychallenge.com/ and click on Submission
Form.
V. Amount of the Prize
The total prize pool for the 2014 FDA Food Safety Challenge is
$500,000. From the $500,000 prize pool, up to 5 finalists will be
awarded $20,000 each following the open submission phase and judging of
submissions. After the field accelerator phase and final
[[Page 57112]]
judging, the winner(s) will receive the remainder of the prize money.
VI. Payment of the Prize
Prizes awarded under this competition will be paid by electronic
funds transfer and may be subject to Federal income taxes. FDA will
comply with the Internal Revenue Service withholding and reporting
requirements, where applicable.
VII. Basis Upon Which Winner(s) Will Be Selected
A panel of expert judges will select up to five finalist teams from
the pool of eligible entries. These finalists will then refine their
concepts during the field accelerator phase and will present the
concept at demo day. The judging will be based and scored upon the
judges' own discretion as to the quality of each entry according to the
following finalist evaluation criteria, with equal weighting (i.e., 20
percent for each).
A. Finalist Evaluation Criteria
Speed: Proposed reduction in time from unprepared food
sample to verified pathogen to subtype/serovar level for Salmonella in
fresh, minimally processed produce. The ability of the solution to also
address testing in other foods and other complex matrices is
encouraged. The ability of the technique to also address additional
pathogens such as Shiga toxin-producing Escherichia coli is encouraged.
Improved detection and path to impact: Strength of
evidence, data, and/or argumentation regarding the application of
submission's technique to create impactful acceleration and improvement
of foodborne pathogen detection, inclusive of improvements in
specificity and sensitivity for Salmonella and possibly other
pathogens.
Applicability: Applicability of solution to FDA testing
processes.
Revolutionary: Whether the concept would be a
revolutionary improvement over the FDA's current testing procedures
with potential to make a major impact on food testing.
Execution: Perceived ability of submitting team or
individual to execute and develop their concept.
B. Winner Selection Criteria
Winner selection criteria will include finalist evaluation criteria
plus the following criterion: Demonstration of team's/individual's
ability to effectively iterate and improve their concept over the
course of the field accelerator phase.
VIII. Additional Information
FDA reserves the right to suspend, postpone, terminate, or
otherwise modify the challenge, or any entrant's participation in the
challenge, at any time at FDA's discretion.
IX. Intellectual Property
Entrants retain ownership of their concepts, including any
software, research, or other intellectual property that they develop in
connection therewith, subject to the license granted to FDA to use
publicly posted materials as set forth herein. By participating in the
challenge, each entrant hereby irrevocably grants to FDA and Luminary
Labs, LLC, a limited, non-exclusive, royalty free, worldwide license
and right to reproduce, publicly perform, publicly display, and use the
submission to the extent necessary to administer the challenge, and to
publicly perform and publicly display the submission abstract,
including, without limitation, for advertising and promotional purposes
relating to the challenge.
Entrants retain all rights in the submission and any invention or
work, including any software, submitted as part of the submission,
subject to the following:
A nonexclusive, nontransferrable, irrevocable, paid-up
license to practice or have practiced for or on behalf of the United
States any such invention or work throughout the world, should the
submission win; and
A license in the submission or work submitted as part of
the submission for the United States to use, disclose, reproduce,
prepare derivative works, distribute copies to the public, and perform
publicly and display publicly, in any manner and for any purpose, and
to have or permit others to do so, should the submission win.
Dated: September 18, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014-22682 Filed 9-23-14; 8:45 am]
BILLING CODE 4164-01-P